Aileen Chew
About Aileen Chew
Aileen Chew is a Regulatory Affairs Specialist currently employed at Nektar Therapeutics in San Francisco, California. She has previous experience as a Drug Safety Associate at BioSoteria, Inc. and InterMune, as well as a Project Consultant at JANSSEN Alzheimer Immunotherapy.
Work at Nektar Therapeutics
Aileen Chew has been employed at Nektar Therapeutics as a Regulatory Affairs Specialist since 2018. In this role, she is responsible for ensuring compliance with regulatory requirements and facilitating the approval process for new therapies. Her work contributes to the development and commercialization of innovative treatments within the biopharmaceutical industry.
Previous Experience in Drug Safety
Prior to her current position, Aileen Chew worked as a Drug Safety Associate at InterMune from 2005 to 2008. During her three years in this role, she was involved in monitoring and reporting adverse events related to drug therapies. She also worked at BioSoteria, Inc. as a Drug Safety Associate from 2008 to 2009, where she continued her focus on drug safety and regulatory compliance.
Consulting Role at JANSSEN Alzheimer Immunotherapy
Aileen Chew served as an Inspection Readiness Project Consultant at JANSSEN Alzheimer Immunotherapy for a brief period in 2011. Her role lasted for three months and involved preparing the organization for regulatory inspections, ensuring that processes and documentation met the necessary standards.
Education and Expertise
Aileen Chew possesses expertise in regulatory affairs and drug safety, developed through her extensive experience in the biopharmaceutical sector. Her background includes roles that required a thorough understanding of compliance, safety monitoring, and regulatory processes, which are essential for the successful development of pharmaceutical products.